Sterling Capital Management’s Quest Diagnostics DGX Stock Holding History

Sterling Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.22M	Buy	5,769 +2,014	+54%	+$395K	0.02%	482
2026 Q1	$736K	Sell	3,755 -2,854	-43%	-$555K	0.01%	606
2025 Q4	$1.15M	Sell	6,609 -283	-4%	-$51.5K	0.02%	598
2025 Q3	$1.31M	Sell	6,892 -528	-7%	-$93.7K	0.02%	547
2025 Q2	$1.33M	Buy	7,420 +1,248	+20%	+$217K	0.02%	530
2025 Q1	$1.04M	Sell	6,172 -407	-6%	-$66.9K	0.02%	596
2024 Q4	$993K	Buy	6,579 +2,346	+55%	+$365K	0.01%	634
2024 Q3	$657K	Buy	+4,233	New	+$632K	0.01%	730
2015 Q1	–	Sell	-6,000	Closed	-$402K	–	898
2014 Q4	$402K	Buy	+6,000	New	+$379K	﹤0.01%	803

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Sterling Capital Management's DGX Position: Q2 2026 in Review

Sterling Capital Management increased its Quest Diagnostics (DGX) stake by 54% in Q2 2026, buying an estimated $395K and bringing the position to 5,769 shares worth $1.22M. The position accounts for 0.02% of the portfolio, ranked #482.

Sterling Capital Management first reported a position in DGX in Q4 2014 and has held it in 9 quarters since. The position peaked at $1.33M in Q2 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Sterling Capital Management held 5,769 shares of Quest Diagnostics worth $1.22M as of Q2 2026.
Sterling Capital Management bought 2,014 Quest Diagnostics shares in Q2 2026, an estimated $395K.
Quest Diagnostics made up 0.02% of Sterling Capital Management's portfolio in Q2 2026, its #482 holding.
Sterling Capital Management first reported a position in Quest Diagnostics in Q4 2014 and has held it in 9 quarters since.
Sterling Capital Management's Quest Diagnostics position peaked at $1.33M in Q2 2025.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.